Abbott Laboratories
$104.12
+1.48 · +1.44% today
Market open · updated 12:44:26 PM ET
- High
- $104.50 7:55 AM
- Low
- $103.00 4:05 AM
Against the S&P 500 Price change through Oct 28, 2026
ABT−18.08%
S&P 500+13.26%
ABT−18.93%
S&P 500+12.41%
ABT+10.54%
S&P 500+88.06%
ABT−19.63%
S&P 500+68.51%
Key numbers
- Previous close
- $102.64
- Open
- $103.79
- Day's range
- $103.00 – $104.62
- 52-week range
- $81.97 – $132.03
- Volume
- 2.8 million
- Average volume
- 10.1 million
- Market value
- $180.2 billion
- Price to earnings
- 38.0last 12 months
- Earnings per share
- $2.70last 12 months
- Beta
- 0.58moves less than the market
- Dividend
- $2.52 a year · 2.45%
- 50-day average
- $104.70
- 200-day average
- $101.89
Analyst price targets and the full financials are in the terminal.
Who Abbott Laboratories competes with From our value chain
Abbott Laboratories in the news
- HeadlineAbbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve diseasePRNewsWire · October 29, 2026 at 9:00 AM ET
- Congress trade disclosuresRep. Pete Sessions Discloses 24 Stock Sales in New FilingsWiseView Research desk · October 28, 2026
- CongressPete Sessions sold $50,001 - $100,000 of ABTHouse filing · disclosed Oct 28, 2026
- HeadlineIs Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?Zacks Investment Research · October 27, 2026 at 10:31 AM ET
- HeadlineIs Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?Zacks Investment Research · October 27, 2026 at 10:01 AM ET
- HeadlineAbbott: Demand Headwinds And Litigation Risks Priced-In - Spin-Off Tailwinds AheadSeeking Alpha · October 27, 2026 at 10:00 AM ET
- HeadlineThis Dividend King Just Announced Great News for InvestorsThe Motley Fool · October 26, 2026 at 1:58 PM ET
- HeadlineAbbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatmentPRNewsWire · October 26, 2026 at 9:00 AM ET
Congress trades in ABT
4 purchases and 4 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Pete SessionsHouse · R-Texas | Sale | $50,001 - $100,000 | Oct 2, 2026 | Oct 28, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Sep 18, 2026 | Oct 12, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Rick AllenHouse · R-Georgia | Sale | $15,001 - $50,000 | Jul 14, 2026 | Aug 19, 2026 |
| Mike KellyHouse · R-Pennsylvania | Sale | $1,001 - $15,000 | Jul 17, 2026 | Aug 12, 2026 |
| Rick LarsenHouse · D-Washington | Sale | $1,001 - $15,000 | Jul 8, 2026 | Jul 13, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Jun 2, 2026 | Jul 8, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Jun 16, 2026 | Jul 3, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 115,000
- Headquarters
- Abbott Park, Illinois
- Website
- abbott.com
- Listed
- Mar 17, 1980
More medical - devices stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.